Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$19.4 - $27.42 $787,252 - $1.11 Million
-40,580 Closed
0 $0
Q1 2021

May 03, 2021

SELL
$25.02 - $54.99 $2,502 - $5,499
-100 Reduced 0.25%
40,580 $1.05 Million
Q4 2020

Feb 02, 2021

BUY
$41.04 - $56.79 $3,693 - $5,111
90 Added 0.22%
40,680 $2.18 Million
Q3 2020

Nov 04, 2020

BUY
$36.42 - $57.0 $16,024 - $25,080
440 Added 1.1%
40,590 $1.67 Million
Q2 2020

Aug 07, 2020

BUY
$39.26 - $52.73 $1.58 Million - $2.12 Million
40,150 New
40,150 $1.95 Million
Q2 2018

Aug 07, 2019

SELL
$15.07 - $22.34 $137,709 - $204,142
-9,138 Closed
0 $0
Q1 2018

Jul 24, 2019

BUY
$22.47 - $32.33 $205,330 - $295,431
9,138 New
9,138 $205,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Treasurer Of The State Of North Carolina Portfolio

Follow Treasurer Of The State Of North Carolina and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

News

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.